Edible antibodies to treat and prevent gastrointestinal disorders

Therapeutic antibodies are increasingly being used in the clinic for the treatment of diseases. Yet, oral to gut targeting of antibodies remains a challenge due to their inability to survive digestion and reach gastrointestinal ...

Closing in on an ulcer- and cancer-causing bacterium

A research team led by scientists at the Chinese University of Hong Kong is releasing study results this week showing how a bacterium, Helicobacter pylori, that causes more than half of peptic ulcers worldwide and that has ...

page 2 from 3